Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIcg-longbow Regulatory News (LBOW)

Share Price Information for Icg-longbow (LBOW)

Share Price is delayed by 15 minutes
Get Live Data
12.00    0.40 (3.15%)
Bid:
12.70
Ask:
13.50
Spread: 0.80 (6.299%)
Market Cap: £14.56m
LBOW Live PriceLast checked at - London Stock Exchange

Intraday Icg-longbow Share Chart

Portfolio Update & Board Changes

30 Jan 2025 18:05

RNS Number : 3610V
ICG-Longbow Snr Sec UK Prop DebtInv
30 January 2025
 

ICG Longbow LEI: 2138008BKBH3OP2CA764

30 January 2025

 

 

ICG-Longbow Senior Secured UK Property Debt Investments Limited

 

(the "Company")

Portfolio Update and Board Changes

Portfolio Update

The Company continues to make progress in exiting its three final investments in what remain challenging market conditions. 

 

Since issuance of the Company's interim report and accounts in October 2024, the asset securing the Affinity loan has been placed under offer for sale following a competitive bidding process, and the Company continues to see buyer interest for the Southport hotel asset, however the exit of this position is taking longer than anticipated. 

 

The Company, its fellow lenders and the operating partner continue to work together to restabilise the portfolio securing the RoyaleLife loan under the new Regency Living brand, with home sales having restarted in earnest in the fourth quarter of 2024. An exit of this portfolio is anticipated when the conditions are right for sale.

 

Board Changes

The board has sought to control the cost base of the Company as assets have shrunk. As noted above, some progress is being made in relation to the remaining three loans and, accordingly, the board has agreed that it is an appropriate time to reduce the size of the board.

 

Stuart Beevor, who has served as Director and Fiona Le Poidevin, who has served as a Director and Chair of the Audit and Risk Committee, will retire from the Board of the Company with effect from 31 January 2025. 

 

Jack Perry and Paul Meader will remain as Directors.

 

The Company also announces the following changes to the roles and responsibilities of some Directors with effect from 31 January 2025, in accordance with listing rule 6.4.6 (2) & (3):

 

Paul Meader will be appointed as Chair of the Audit and Risk Committee with effect from 31 January 2025 following Fiona Le Poidevin's retirement.

 

The Company extends its thanks to Stuart and Fiona for their hard work and wise counsel during their tenures.

 

For further information, please contact:

Ocorian Administration (Guernsey) Limited:

Louise Manklow

+44 (0)14 8174 2742

 

Cavendish:

James King

Daniel Balabanoff

+44 (0)20 7397 1910

+44 (0)20 7397 1909

 

ICG Real Estate:

David Mortimer

 

 

+44 (0)20 3545 138

 

 

Further information on the Company can be found on its website at http://www.lbow.co.uk/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUBMMPTMTMJBJA
Date   Source Headline
6th Apr 20224:35 pmRNSPrice Monitoring Extension
1st Apr 202210:44 amRNSDirector/PDMR Shareholding
29th Mar 20224:33 pmRNSDirector/PDMR Shareholding
28th Mar 20229:05 amRNSDirector/PDMR Shareholding
24th Mar 20227:01 amRNSInterim Dividend Announcement
24th Mar 20227:00 amRNSQuarterly Update
7th Mar 20224:36 pmRNSPrice Monitoring Extension
4th Mar 20227:00 amRNSDirector Declaration
18th Feb 20224:41 pmRNSSecond Price Monitoring Extn
18th Feb 20224:35 pmRNSPrice Monitoring Extension
19th Jan 20224:41 pmRNSSecond Price Monitoring Extn
19th Jan 20224:36 pmRNSPrice Monitoring Extension
11th Jan 20224:01 pmRNSReturn of Capital and NAV
20th Dec 20211:01 pmRNSPortfolio Update
9th Dec 20217:00 amRNSQuarterly Update
7th Dec 20217:01 amRNSInterim Dividend Announcement
7th Dec 20217:00 amRNSReturn of Capital and NAV
29th Nov 20217:00 amRNSPortfolio Update
18th Oct 20217:00 amRNSDirector/PDMR Shareholding
18th Oct 20217:00 amRNSDirector/PDMR Shareholding
12th Oct 20214:07 pmRNSDirector/PDMR Shareholding
6th Oct 20215:24 pmRNSDirector/PDMR Shareholding
30th Sep 20217:01 amRNSHalf-Year Report
30th Sep 20217:00 amRNSInterim Dividend Announcement
23rd Sep 20214:40 pmRNSSecond Price Monitoring Extn
23rd Sep 20214:35 pmRNSPrice Monitoring Extension
14th Sep 20217:00 amRNSQuarterly Update
13th Sep 202110:14 amRNSReturn of Capital and NAV
5th Aug 20218:36 amRNSPortfolio Update
28th Jun 20216:26 pmRNSInterim Dividend Declaration - Replacement
28th Jun 20213:08 pmRNSDirectorate Change
28th Jun 20213:06 pmRNSResult of AGM
28th Jun 20211:41 pmRNSDividend Declaration
17th Jun 20217:00 amRNSQuarterly Update
12th May 202110:25 amRNSDirector/PDMR Shareholding
10th May 202110:03 amRNSNotice of AGM
10th May 20217:00 amRNSAnnual Report for the year ended 31 January 2021
24th Mar 20213:42 pmRNSInterim Dividend Declaration
16th Mar 20217:00 amRNSQuarterly Update
14th Jan 20213:45 pmRNSResults of Extraordinary General Meeting
13th Jan 20217:00 amRNSPortfolio Update
16th Dec 20207:00 amRNSCircular & Notice of Extraordinary General Meeting
11th Dec 20205:27 pmRNSCommittee Appointments
11th Dec 20207:00 amRNSInterim Dividend Announcement
8th Dec 20207:00 amRNSQuarterly Update
25th Nov 20207:00 amRNSChange of Management Arrangements
12th Nov 20207:00 amRNSPortfolio Update
3rd Nov 20207:00 amRNSOrderly Realisation and Return of Capital
21st Oct 20207:00 amRNSPortfolio Update
20th Oct 20206:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.